FDA Inspection 1110439 — Silvia Stacchiotti, M.D.
The FDA completed an inspection of Silvia Stacchiotti, M.D. on October 24, 2019 in Milan. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 24, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Milan (Italy)
Additional Details
Clinical Investigator (CI)